Search by Drug Name or NDC
NDC 67457-0198-05 Ultiva 1 mg/mL Details
Ultiva 1 mg/mL
Ultiva is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is REMIFENTANIL HYDROCHLORIDE.
Product Information
| NDC | 67457-0198 |
|---|---|
| Product ID | 67457-198_2fa2e80a-ad02-4813-b595-1074422e01e9 |
| Associated GPIs | 65100087102110 65100087102120 65100087102150 |
| GCN Sequence Number | 028228 |
| GCN Sequence Number Description | remifentanil HCl VIAL 1 MG INTRAVEN |
| HIC3 | H3H |
| HIC3 Description | OPIOID ANALGESIC, ANESTHETIC ADJUNCT AGENTS |
| GCN | 07213 |
| HICL Sequence Number | 011931 |
| HICL Sequence Number Description | REMIFENTANIL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Ultiva |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Remifentanil Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | REMIFENTANIL HYDROCHLORIDE |
| Labeler Name | Mylan Institutional LLC |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA020630 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67457-0198-05 (67457019805)
| NDC Package Code | 67457-198-05 |
|---|---|
| Billing NDC | 67457019805 |
| Package | 10 VIAL, GLASS in 1 CARTON (67457-198-05) / 5 mL in 1 VIAL, GLASS (67457-198-99) |
| Marketing Start Date | 1996-11-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |